Sub menu

 
 

International scientific guidelines: CHMP SWP conclusions and recommendations on the use of genetically modified animal models for carcinogenicity assessment

CPMP/SWP/2592/02 Rev 1 adopted by the Therapeutic Goods Administration (TGA)

About this guideline

Overseas effective date: 25 May 2015

Categories: Nonclinical | Toxicology | Carcinogenicity

Access this international scientific guideline

For more information see International scientific guidelines adopted in Australia.

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.

Help us improve the Therapeutic Goods Administration site